Concepedia
Statistics
Publications
8
Citations
3.5K
H-Index
Active since
2004
Affiliations
AstraZeneca (United States)(Current)
University of Colorado Denver
The University of Texas MD Anderson Cancer Center
Center for Cancer Research
The Barbara Ann Karmanos Cancer Institute
Annetta Krebs is an author at AstraZeneca (United States) specializing in pharmacotherapy, cancer therapeutics, and lung cancer.
Top concepts
MedicineOncologyLung CancerCancer TherapyPharmacotherapyRadiation Oncology
Publications per year
2004–2013
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2
Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller et al. · Journal of Clinical Oncology · 2004 · 1.7K citations · Full text
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat et al. · Journal of Clinical Oncology · 2005 · 607 citations
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells, Jessica E. Gosnell, Robert F. Gagel et al. · Journal of Clinical Oncology · 2010 · 513 citations · Full text
Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Bruce G. Robinson, Luis Paz‐Ares, Annetta Krebs et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 254 citations · Full text
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
John V. Heymach, Luis Paz‐Ares, Filippo de Braud et al. · Journal of Clinical Oncology · 2008 · 219 citations
1–5 of 8